Abstract

IntroductionCholera is a highly infectious disease and remains a serious public health burden in Bangladesh. The objective of the study was to measure the private demand for oral cholera vaccines (OCV) in Bangladesh and to investigate the key determinants of this demand, reflected in the household’s willingness to pay (WTP) for oral cholera vaccine.MethodsA contingent valuation method was employed in an urban setting of Bangladesh during December 2015 to January 2016. All respondents (N = 1051) received a description of World Health Organization (WHO) prequalified OCV, Shanchol™. Interviews were conducted with either the head of households or their spouse or a major economic contributor of the households. Respondents were asked about how much at maximum they were willing to pay for OCV for their own and their household members’ protection. Results are presented as the average and median of the reported maximum WTP of the respondents with standard deviations and 95% confidence interval. Natural log-linear regression model was employed to examine the factors influencing participants’ WTP for OCV.ResultsAbout 99% of the respondents expressed WTP for OCV with a maximum mean and median WTP per vaccination (2 doses) of US$ 2.23 and US$ 1.92 respectively. On the household level with an average number of 4.62 members, the estimated mean WTP was US$ 10 (median: US$ 7.69) which represents the perceived demand for OCV of a household to vaccinate against cholera.ConclusionsThe demand of vaccination further indicates that there is a potential scope for recovering a certain portion of the expenditure of immunization program by introducing direct user fees for future cholera vaccination in Bangladesh. Findings from this study will be useful for the policy-makers to make decision on cost-recovery in future oral cholera vaccination programs in Bangladesh and in similar countries.

Highlights

  • Cholera is a highly infectious disease and remains a serious public health burden in Bangladesh

  • Willingness to pay for oral cholera vaccines

  • Willingness to pay for oral cholera vaccines for future vaccines [15]

Read more

Summary

Introduction

Cholera is a highly infectious disease and remains a serious public health burden in Bangladesh. Bangladesh has one of the largest burdens of endemic cholera, with an estimated 109,052 cases each year, and approximately 66 million people are at risk of cholera [2]. The endemicity of cholera in Bangladesh is demonstrated by the predictable yearly occurrence of the disease in the country’s high-risk districts and the repetitive seasonal pattern of cholera outbreaks, in spring or autumn, or both [4]. Residents of urban slums in Dhaka are still vulnerable to cholera infection [6,7] To address this problem, policy makers recognized that an effective vaccine and vaccination strategy are essential for urban Bangladesh [3]. Few of them (2%) reportedly lived in soil/mud-based floor

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call